Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01477125
Other study ID # X002
Secondary ID DAT-NSPDAT-KV
Status Completed
Phase N/A
First received
Last updated
Start date November 2013
Est. completion date June 15, 2018

Study information

Verified date September 2020
Source Karolinska Institutet
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to evaluate whether computerised working memory training improves cognitive performance, ADHD symptoms, psychosocial functioning and quality of life in adults with ADHD, from psychiatric outpatient clinics (N=100) as well as from a high-security prison facility (N=50).


Description:

The primary aim is to evaluate whether 5 weeks of computerised working memory training improves working memory capacity. Secondary aims are to explore whether improvements in working memory capacity will be transferred to improvements in learning abilities and fluid intelligence. Also, far transfer effects on executive functioning, ADHD symptoms, psychosocial functioning and quality of life will be explored. Finally, it will also be assessed to what extent improvements gained from 5 weeks of working memory training will be maintained 3 and 6 months post-study, respectively.


Recruitment information / eligibility

Status Completed
Enrollment 102
Est. completion date June 15, 2018
Est. primary completion date December 15, 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- Confirmed ADHD according to DSM-IV criteria; ADHD combined type, ADHD inattentive type or ADHD UNS, primarily inattentive type.

- Unmedicated for ADHD during the course of the trial, or being under stable ADHD medication for at least one month at baseline visit and without any planned changes in medication until post-study assessments have taken place.

Exclusion Criteria:

- Previous participation in computerised working memory training (completed training).

- Any psychiatric disorder that in the judgment of the investigator, may interfere with study participation and/or study assessments, also including current substance abuse.

- Participation in psychological treatment addressing ADHD during the course of the 5-week training period (psychoeducation is accepted).

- Initiation of psychological treatment for coexistent disorders during the course of the study (treatment already ongoing at baseline visit is accepted if there are no planned changes during the 5-week training period).

Study Design


Related Conditions & MeSH terms

  • Attention Deficit Disorder with Hyperactivity
  • Attention Deficit Hyperactivity Disorder

Intervention

Behavioral:
Flex working memory training
30-40 minutes of working memory training, 5 days a week for 5 weeks

Locations

Country Name City State
Sweden Karolinska Institutet Stockholm

Sponsors (4)

Lead Sponsor Collaborator
Karolinska Institutet Stockholm County Council, Sweden, Swedish Prison and Probation Services, The Söderströmska-Königska Foundation

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in a composite measure of working memory capacity The composite measure of working memory capacity comprises the sum score of:
Digit Span score (forwards/backwards)
Span Board score (forwards/backwards)
Arithmetics score
Spatial Working Memory score
Baseline and 7 weeks
Secondary Change in a composite measure of working memory capacity The composite measure of working memory capacity will be assessed in a 6-month follow-up conducted at week 31 post-baseline, equivalent to week 24 post-intervention, to assess retention of any training-related improvements. Baseline and 31 weeks
Secondary Change in Digit Span Forwards/Backwards score Evaluating changes in both Digit Span forwards and backwards scores, as measures of simple verbal working memory capacity. Baseline, 7 and 31 weeks
Secondary Change in Span Board Forwards/Backwards score Evaluating changes in both Span Board forwards and backwards scores as measures of simple visuo-spatial working memory capacity. Baseline, 7 and 31 weeks
Secondary Change in Arithmetics score Evaluating change in Arithmetics score, as a measure of complex verbal working memory capacity as well as of mathematics ability. Baseline, 7 and 31 weeks
Secondary Change in Spatial Working Memory score Evaluating change in Spatial Working Memory score as a measure of complex visuo-spatial working memory capacity. Baseline, 7 and 31 weeks
Secondary Change in Qbtest scores Evaluating changes in Qbtest, a computerised CPT that in addition to measuring inattention and impulsivity also captures motor activity by an IR device during performance of the CPT. Baseline, 7 and 31 weeks
Secondary Change in Raven´s Standard Progressive Matrices score Evaluating change in score of a short version of RavenĀ“s Standard Progressive Matrices, as a measure of fluid intelligence. Baseline, 7 and 31 weeks
Secondary Change in Adult ADHD Self-Report Scale (ASRS-v1.1) Symptom Checklist Evaluating changes in ADHD symptoms by self-reported and informant-reported (significant other) versions of ASRS-v1.1, conducted at baseline, post-intervention, at 3-month and 6-month follow-up. Baseline, 7, 19, and 31 weeks
Secondary Change in Sheehan Disability Scale (SDS) Evaluating changes in psychosocial functioning by the self-reported SDS conducted at baseline, post-intervention, at 3-month and 6-month follow-up. Baseline, 7, 19, and 31 weeks
Secondary Change in EuroQol- 5 Dimensions (EQ-5D) questionnaire Evaluating change in health-related quality of life by the self-reported generic QoL questionnaire EQ-5D, conducted at baseline, post-intervention, at 3-month and 6-month follow-up. Baseline, 7, 19, and 31 weeks
Secondary Change in Adult ADHD Quality of Life Measure (AAQoL) Evaluating change in health-related quality of life by the self-reported ADHD specific QoL measure AAQoL, conducted at baseline, post-intervention, at 3-month and 6-month follow-up. Baseline, 7, 19, and 31 weeks
Secondary Montgomery Åsberg Depression Rating Scale-Self report (MADRS-S) Evaluating if depressive symptoms during the training period, as measured by the self-reported MADRS-S will influence adherence to and results of the working memory training. Baseline and 7 weeks
Secondary Adverse events All adverse events that occurred during the course of the 5-week intervention will be collected as part of the post-intervention assessments at week 7. Baseline and 7 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT06129396 - Effects of Aerobic Exercise Intervention in Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD) N/A
Completed NCT04779333 - Lifestyle Enhancement for ADHD Program 2 N/A
Recruiting NCT05935722 - Evaluation of a Home-based Parenting Support Program: Parenting Young Children N/A
Completed NCT03148782 - Brain Plasticity Underlying Acquisition of New Organizational Skills in Children-R61 Phase N/A
Completed NCT04832737 - Strength-based Treatment Approach for Adults With ADHD N/A
Recruiting NCT04631042 - Developing Brain, Impulsivity and Compulsivity
Recruiting NCT05048043 - Development of a Game-supported Intervention N/A
Completed NCT03337646 - Evaluation of the Effect and Safety of Lisdexamfetamine in Children Aged 6-12 With ADHD and Autism Phase 4
Not yet recruiting NCT06406309 - Settling Down for Sleep in ADHD: The Impact of Sensory and Arousal Systems on Sleep in ADHD N/A
Not yet recruiting NCT06454604 - Virtual Reality Treatment for Emerging Adults With ADHD Phase 2
Not yet recruiting NCT06080373 - Formulation-based CBT for Adult Inmates With ADHD: A Randomized Controlled Trial N/A
Completed NCT02911194 - a2 Milk for Autism and Attention-deficit Hyperactivity Disorder (ADHD) N/A
Completed NCT02477280 - Effects of Expectation, Medication and Placebo on Objective and Self-rated Performance Phase 4
Completed NCT02390791 - New Technologies to Help Manage ADHD N/A
Completed NCT02473185 - Effects of Expectation, Medication and Placebo on Objective and Self-rated Performance During the QbTest Phase 4
Completed NCT02555150 - A Comparison of PRC-063 and Lisdexamfetamine in the Driving Performance of Adults With ADHD Phase 3
Completed NCT02829970 - Helping College Students With ADHD Lead Healthier Lifestyles N/A
Completed NCT02780102 - Cognitive-Motor Rehabilitation, Stimulant Drugs, and Active Control in the Treatment of ADHD N/A
Recruiting NCT04296604 - Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations N/A
Recruiting NCT04175028 - Neuromodulation of Executive Function in the ADHD Brain N/A